Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Vertex Pharmaceuticals saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 94 to 96.

This stock could make you a fortune in the next two years, or lose you a whole lot of money.

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 20, Bank of America Securities lowered the price target on ...

The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Sun Pharma is transitioning its US business from low-margin generics to high-value specialty and innovative therapies.

Vertex Pharmaceuticals shares surged Tuesday after the company posted promising results from a clinical trial of a drug to treat kidney disease.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at pharmaceuticals stocks, starting with ...